文献速递鼻科咽喉与嗓音

阿司匹林加重性呼吸系统疾病的治疗实践:全国保险理赔数据库分析

Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-11-06

基于2009至2015年MarketScan数据库,识别5628例阿司匹林加重性呼吸系统疾病(AERD)患者,其中7%接受阿司匹林脱敏(AsaD),39%接受鼻窦手术。脱敏患者中58%接受手术,多数手术在脱敏前约61天进行;脱敏后再次手术间隔较长。

要点

  • 仅7%的AERD患者接受阿司匹林脱敏治疗。
  • 接受脱敏的患者中58%接受手术,其中88%手术在脱敏前进行。
  • 脱敏患者再次手术间隔中位数长于未脱敏者(734天 vs 287天)。

核心结论

  • 极少数AERD患者接受阿司匹林脱敏治疗。
  • 接受脱敏的患者多在脱敏前约2个月进行手术。
  • 接受脱敏的患者再次手术间隔时间较未脱敏者延长。

研究设计与样本

  • 基于MarketScan数据库2009至2015年的回顾性队列分析。
  • 使用ICD-9编码识别哮喘、鼻息肉和药物过敏患者,共5628例符合AERD标准。
  • 通过CPT编码确定药物脱敏和鼻内手术操作。

主要发现

  • 患者平均年龄46岁,女性占60%。
  • 395例(7%)接受阿司匹林脱敏,2171例(39%)接受鼻窦手术。
  • 脱敏患者中229例(58%)接受手术,其中201例(88%)手术在脱敏前进行,中位时间61天(Q1-Q3:30-208)。
  • 脱敏后接受手术者(n=46)手术中位时间在脱敏后302天(163-758)。

临床怎么用

  • AERD患者接受阿司匹林脱敏的比例较低,需关注治疗模式差异。
  • 脱敏治疗可能与延长再次手术间隔相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is the triad of asthma, nasal polyposis, and sensitivity to cyclooxygenase-1 inhibitors. Treatment options include medical management, surgical intervention, and aspirin desensitization (AsaD). METHODS: AERD patients were identified using the MarketScan Database from 2009 to 2015. Patients were included using International Classification of Diseases, 9th edition (ICD-9) codes for asthma, nasal polyposis, and drug allergy. Treatments were determined by Current Procedural Terminology (CPT) codes for drug desensitization and endonasal procedures. Geographic trends and timing of interventions between those exposed and not exposed to desensitization were explored. RESULTS: A total of 5628 patients met inclusion criteria for AERD, with mean age 46 years, 60% female; 395 (7%) underwent AsaD and 2171 (39%) underwent sinus surgery. Among patients who were desensitized, 229 (58%) underwent surgery, of whom 201 (88%) had surgery prior to AsaD (median [quartile 1, quartile 3]; 61 days [30, 208] prior to desensitization). For patients undergoing surgery following AsaD (n = 46), surgery was performed a median of 302 (163, 758) days after AsaD. Nineteen patients had multiple surgeries post-AsaD with median time between surgeries being 734 days (312, 1484); 261 patients were not desensitized to aspirin but did undergo multiple surgeries, with the median of the median time between surgeries being 287 days (15, 617), which is shorter than for patients post-AsaD (p < 0.001). CONCLUSION: A very small percentage of AERD patients undergo AsaD. Patients who had AsaD underwent surgery approximately 2 months prior to AsaD. Patients who underwent AsaD experienced an increased time between surgeries compared to patients who did not undergo AsaD.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Roland LT, Nagy C, Wang H, et al. Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database. Int Forum Allergy Rhinol. 2019. PMID: 31693796. doi:10.1002/alr.22471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。